(Reuters) -Shares in AstraZeneca fell more than 4% on Wednesday after a data abstract on its experimental precision drug's use in lung cancer patients in a late-stage trial disappointed some analysts.
Data supports the novel Trans-Arterial Micro-Perfusion (TAMP TM) therapy platform for targeted chemotherapy delivery for the potential to minimize a therapy’s toxicities versus systemic intravenous ...
Abstract Security, crafted by category creators who redefined the cybersecurity landscape, announced the general availability (GA) of its platform designed for the future of security operations.
The scientific abstract program of the United States and Canadian Academy of Pathology (USCAP) annual meeting is an important forum for sharing recent advances in pathology, publishing more than 1500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results